data-standards-995x60.png data-standards-995x60.png

FEATURED ARTICLES

  • Breakthrough Therapy Designation Helps Genentech Navigate Difficult Trials
    Breakthrough Therapy Designation Helps Genentech Navigate Difficult Trials

    FDA started the Breakthrough Therapy Designation program in 2012. Since then, Genentech has garnered 15 designations, more than any other company. Jeffrey Siegel has been an instrumental component of that success. Siegel is Genentech’s senior group medical director and spent 14 years with FDA prior to joining the company. He has spent most of his career in pharma developing products to address the unmet medical needs of patients. 

  • What Will Clinical Research Certification Mean To Pharma?
    What Will Clinical Research Certification Mean To Pharma?

    The National Board of Medical Examiners (NBME) is a not-for-profit organization that has been around for over 100 years. Its primary mission is assessing the qualifications of healthcare professionals. More recently, the group has been looking into developing an assessment that would be helpful to clinical researchers.

  • TransCelerate Seeks To Improve Clinical Trial Quality
    TransCelerate Seeks To Improve Clinical Trial Quality

    TransCelerate Biopharma is all about collaboration. The group’s goal is to identify, prioritize, design, and facilitate the implementation of solutions to help sponsors efficiently and effectively produce needed medicines for patients. In this interview Deb Driscoll, VP of quality assurance at Merck and lead of the TransCelerate QMS (quality management system), discusses how the initiative hopes to improve quality in clinical trials.

More Featured Articles

WHITE PAPERS AND CASE STUDIES

  • What The Fitbit Is Helping Pharma Learn About Patients
    What The Fitbit Is Helping Pharma Learn About Patients

    Fitness trackers were popular holiday gifts this year and sales are on the rise. While counting steps and getting fit may be the primary reason consumers are purchasing Fitbits and other wearables, other sensors these devices include, such as heart rate and sleep monitors, could actually help big pharma collect a wealth of valuable data to revolutionize personalized medicine.

  • Electronic Informed Consent: Considerations For Implementation In Clinical Trials
    Electronic Informed Consent: Considerations For Implementation In Clinical Trials

    In an era where data acquisition (eg. ePRO), capture (EDC) and storage (eTMF) are done electronically, it is the logical consequence to do the same for the informed consent process as all the advantages of the electronic modality equally apply to this process.

  • End-To-End Management Of Clinical Trials Data
    End-To-End Management Of Clinical Trials Data

    The introduction of electronic data capture (EDC) systems in clinical trial data management and analysis triggered the promise of better-managed clinical trials – with greater efficiency, faster access to higher-quality clinical data and better mapping of data flows to business processes.

More White Papers & Case Studies

SERVICES AND PRODUCTS

Regulatory Submissions Regulatory Submissions
Regulatory submissions are the most critical milestones in your clinical research program. Quality submissions can accelerate time to market, bring the benefit of new treatments to patients sooner, maximize research investments, and conserve patent life.
Phase I Services Phase I Services
For the early stages of drug development, Rho provides packages for Phase I clinical trials that have predictable cost structures.
Consulting Consulting
Clinical trials involve a myriad of complicated processes and variables. Rho can help you navigate the clinical trial process to save you time and minimize costs.
Clinical Services Clinical Services
Our clients make substantial investments in clinical research services that advance products with the potential to improve health and prevent disease. We believe this is important.
Comprehensive Capabilities Comprehensive Capabilities
Rho has been supporting clinical research at pharmaceutical, biotech, and medical device companies for 25 years and is an expert in providing end-to-end services.
Data Standards Data Standards
Data Standards is one of Rho's strongest capabilities and one of the services most in demand by our clients. Our company's distinct advantage is our knowledge of the standards and the tools we have developed to support their use.
More Services & Products